By Meds Connect India | Pharmaceutical Exporter & Drop-Shipping Company from India
Product Description
Bortenat 3.5 mg Injection contains Bortezomib, an antineoplastic medicine used in the treatment of certain blood cancers, including multiple myeloma and mantle cell lymphoma. It works by inhibiting proteasomes, structures inside cells that help regulate protein breakdown. This action can interfere with the growth and survival of cancer cells.
Product Name: Bortenat 3.5 mg Injection
Active Ingredient: Bortezomib
Strength: 3.5 mg per vial
Dosage Form: Powder for solution for injection
Therapeutic Category: Antineoplastic / Proteasome Inhibitor
Manufacturer/Brand: Natco Pharma Ltd. (Bortenat)
Advantages and Potential Benefits
Used in specialist-directed treatment regimens for certain blood cancers.
May be prescribed alone or in combination with other cancer medicines, depending on the patient's condition.
Available as a 3.5 mg vial for preparation and administration by qualified healthcare professionals.
Disadvantages and Possible Side Effects
Bortezomib can cause side effects, which may vary between patients. These include:
Peripheral neuropathy, such as numbness, tingling, or pain in the hands and feet
Low platelet or white blood cell counts
Nausea, diarrhoea, or constipation
Fatigue and weakness
Fever and increased risk of infections
Changes in blood pressure
Serious complications can occur. Treatment requires monitoring by an oncologist. This medicine must not be self-administered.
Shipping and International Availability
Meds Connect India coordinates pharmaceutical export and drop-shipping enquiries from India, subject to product availability and applicable regulations.
We receive international enquiries from countries and regions including:
USA and Canada
United Kingdom
Australia and New Zealand
Singapore
South Korea and Japan
Selected European and other international markets
Shipping Information:
Shipping options are assessed according to destination and product eligibility.
Shipping charges and estimated delivery timelines are confirmed during the quotation process.
Packaging, handling, and transport conditions must follow the product's approved requirements.
Customs clearance, import permits, and prescription documentation may be required.
Availability and shipment to any destination are not guaranteed. Bortezomib is a prescription-only oncology medicine and may be subject to additional import, export, and handling restrictions.
Why Choose Meds Connect India?
Meds Connect India is an India-based medicine exporter and drop-shipping company with five years of experience in pharmaceutical sourcing and international order coordination.
Assistance with product availability enquiries
Support for individual and bulk requirements, where permitted
Clear quotations and order communication
International shipping coordination for eligible orders
Customer support during the enquiry and order process
Frequently Asked Questions
1. What is Bortenat 3.5 mg used for?
It contains bortezomib and is used under specialist supervision for certain blood cancers, including multiple myeloma and mantle cell lymphoma.
2. Is Bortenat 3.5 mg a prescription medicine?
Yes. It is a prescription-only oncology medicine and must be used under the direction of a qualified oncologist.
3. How is Bortenat administered?
It is administered by a qualified healthcare professional by an approved injection route. The preparation and administration must follow the official product information.
4. Can Bortenat 3.5 mg be shipped internationally?
International shipment depends on product eligibility, export permissions, destination-country import laws, and required documentation.
5. How can I enquire about Bortenat 3.5 mg?
Contact Meds Connect India with your required quantity and destination country to request an availability check and quotation.
Meds Connect India – Your International Pharmaceutical Export Partner from India.
Contact Us through:
WhatsApp / Telegram: +91-9226917643
📧 Email: medsconnectindia@gmail.com